This is a working overview of regulatory status, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-14 and is reviewed periodically as new material appears.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
=== Natural occurrence === Because of the short half-life of all known isotopes of fermium, any primordial fermium, that is fermium present on Earth during its formation, has decayed by now. Synthesis of fermium from naturally occurring uranium and thorium in the Earth's crust requires multiple neutron captures, which is extremely unlikely. Therefore, most fermium is produced on Earth in laboratories, high-power nuclear reactors, or in nuclear tests, and is present for only a few months afterward. The transuranic elements up to fermium should have been present in the natural nuclear fission reactor at Oklo, but any quantities produced then would have long since decayed away.
In what could be the first global scientific analysis of plastic pollution of lakes and reservoirs that is not limited to recently increasingly studied microplastics, a large team of researchers reports high prevalence and vulnerability factors. In what could be the first global scientific analysis of agricultural pesticide pollution, scientists report that of the studied third of the three million metric tons of pesticides used annually, ~10% remains as toxic residue in soil while rivers receive at least 730 tons where they nearly do not degrade. A study suggests chemical alternatives to age reversal via Yamanaka factors gene therapy are feasible via early in vitro fibroblasts data. On 3 July, researchers report subcutaneous administration of longevity factor α-klotho enhanced cognition in old rhesus macaques. On 27 July, a study shows rejuvenation effects in mice from heterochronic parabiosis endure after the joined mice are detached.
The government of Nkrumah was subsequently overthrown in a coup by the Ghana Armed Forces, codenamed "Operation Cold Chop". This occurred while Nkrumah was abroad with Zhou Enlai in the People's Republic of China, on a mission to Hanoi, Vietnam, to help end the Vietnam War. The coup took place on 24 February 1966, led by Colonel Emmanuel Kwasi Kotoka and Brigadier Akwasi Afrifa. The National Liberation Council was formed, chaired by Lieutenant General Joseph A. Ankrah. A series of alternating military and civilian governments, mostly affected by economic instabilities, ruled Ghana from 1966, ending with the ascent to power of Flight Lieutenant Jerry John Rawlings of the Provisional National Defence Council in 1981. These changes resulted in the suspension of the constitution in 1981 and the banning of political parties. The economy declined, so Rawlings negotiated a structural adjustment plan, changing some economic policies, and growth recovered during the 1980s. A new constitution restoring multi-party system politics was promulgated in the presidential election of 1992, in which Rawlings was elected, and again in the general election of 1996. In a tribal war in Northern Ghana in 1994, between the Konkomba and other ethnic groups, including the Nanumba, Dagomba and Gonja, between 1,000 and 2,000 people were killed and 150,000 people were displaced.
Wound myiasis occurs when fly larvae infest open wounds. It has been a serious complication of war wounds in tropical areas and is sometimes seen in neglected wounds in most parts of the world. Predisposing factors include poor socioeconomic conditions, extremes of age, neglect, mental disability, psychiatric illness, alcoholism, diabetes, and vascular occlusive disease.
Sources: en.wikipedia.org
Waschkies et al. studied the structure of dilute to concentrated freeze-casts from low (< 1 μm s−1) to extremely high (> 700 μm s−1) solidification velocities. From this study, they were able to generate morphological maps for freeze-cast structures made under various conditions. Maps such as these are excellent for showing general trends, but they are quite specific to the materials system from which they were derived. For most applications where freeze-casts will be used after freezing, binders are needed to supply strength in the green state. The addition of binder can significantly alter the chemistry within the frozen environment, depressing the freezing point and hampering particle motion leading to particle entrapment at speeds far below the predicted vc. Assuming, however, that we are operating at speeds below vc and above those which produce a planar front, we will achieve some cellular structure with both ice-crystals and walls composed of packed ceramic particles. The morphology of this structure is tied to some variables, but the most influential is the temperature gradient as a function of time and distance along the freezing direction. Freeze-cast structures have at least three apparent morphological regions. At the side where freezing initiates is a nearly isotropic region with no visible macropores dubbed the Initial Zone (IZ). Directly after the IZ is the Transition Zone (TZ), where macropores begin to form and align with one another. The pores in this region may appear randomly oriented.
They have improved a process from Monsanto by using ultrafiltration to concentrate the incoming lignosulfonates, which reduces the amount of NaOH used and waste produced. The basic chemistry is unchanged: alkaline oxidation using a metal catalyst such a copper salt. According to Scientific American, vanillin produced this way contains aromatic impurities that add strength and creaminess to its flavor. This is probably due to acetovanillone being present.
The low budget of the project proved to be a significant challenge, as well as the unique challenges of working with child actors. The producers wanted the style of the series to reflect trends begun in other popular and innovative TV shows such as Sesame Street and Laugh-In. Puppetry and animation were frequently used. Sometimes one or two of the kids would conduct "man-on-the-street" interviews, asking ordinary citizens about nutrition-related topics. All of the music, including the theme song and the various songs sung by the kids during an episode (many times in musical "romps" reminiscent of the ones seen on The Monkees TV series), were composed and arranged by Washington, DC musician and recording engineer Paul Brier, and performed by a rock combo credited on screen as "The Eye". Mulligan Stew premiered on October 4, 1972, during the National 4-H Week at the National 4-H Center in Washington, DC. The program was considered a success, especially by previous standards for television outreach sponsored by 4-H. The series had a moderate impact on kids making better choices in what they ate, and provided 4-H with a sizable marketing, promotional and public relations boost. Thanks in part to the popularity of Mulligan Stew, 4-H membership was boosted to an all-time high in 1974, and the series continued to air in reruns on public television until 1981.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.